BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21087389)

  • 21. [A partial nephrectomy in renal cell carcinoma].
    Masuda F; Suzuki H; Kurauchi H; Mitani H; Kawahara M; Nishida A
    Gan No Rinsho; 1989 Aug; 35(9):1025-9. PubMed ID: 2671430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.
    Jeon HG; Lee SR; Kim KH; Oh YT; Cho NH; Rha KH; Yang SC; Han WK
    Urology; 2010 Sep; 76(3):574-9. PubMed ID: 20303148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative morbidity and renal function in young and elderly patients undergoing elective nephron-sparing surgery or radical nephrectomy for renal tumours larger than 4 cm.
    Roos FC; Brenner W; Jäger W; Albert C; Müller M; Thüroff JW; Hampel C
    BJU Int; 2011 Feb; 107(4):554-61. PubMed ID: 20707798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
    Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
    J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
    Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
    J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological characteristics of adult renal tumours: a preliminary report.
    Latif F; Mubarak M; Kazi JI
    J Pak Med Assoc; 2011 Mar; 61(3):224-8. PubMed ID: 21465932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological pattern of renal cell carcinoma in Ibadan.
    Odubanjo MO; Oluwasola AO; Ikuerowo SO; Akang EE
    Afr J Med Med Sci; 2010 Dec; 39(4):317-21. PubMed ID: 21735998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of oncological outcomes of transperitoneal and retroperitoneal laparoscopic radical nephrectomy for the management of clear-cell renal cell carcinoma: a multi-institutional study.
    Ha US; Hwang TK; Kim YJ; Oh TH; Jeon YS; Lee W; Lim JS; Lee TY; Choi Y; Park SK; Byun SS
    BJU Int; 2011 May; 107(9):1467-72. PubMed ID: 20825400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical treatment of perplexing renal cell carcinoma].
    Lin Z; Chen S; Ye C
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):463-4. PubMed ID: 10920947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-pathologic study of renal cell carcinoma].
    Moreno Cerro AM; Martínez Tello FJ; Leiva Galvis O; Caballero Alcántara J; Carrero López V; Usera Sárraga G
    Actas Urol Esp; 1992 Oct; 16(9):705-14. PubMed ID: 1488924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
    Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.
    Woldu SL; Barlow LJ; Patel T; Hruby GW; Benson MC; McKiernan JM
    Urology; 2010 Sep; 76(3):639-42. PubMed ID: 20163841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.